Healthcare
•3734 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (3734)
| Company | Market Cap | Price |
|---|---|---|
|
RDGL
Vivos Inc.
RDGL's core offering is radiopharmaceutical therapy using Y-90 for targeted cancer treatment.
|
$33.31M |
$0.07
|
|
GOCO
GoHealth, Inc.
GoHealth's core offering is health insurance enrollment and management for Medicare plans.
|
$33.02M |
$1.17
-2.92%
|
|
MYO
Myomo, Inc.
MyoPro is a prosthetic upper-limb device designed to replace or assist movement for partially paralyzed limbs, fitting Prosthetics & Implants.
|
$33.02M |
$0.86
+7.70%
|
|
POCI
Precision Optics Corporation, Inc.
The business includes design and manufacture of components/subassemblies for medical devices, i.e., Medical Device Components.
|
$32.94M |
$4.19
+4.49%
|
|
XLO
Xilio Therapeutics, Inc.
Xilio is a clinical-stage biotechnology company focused on oncology therapies, placing it in Biotech - Oncology.
|
$32.14M |
$8.58
+2.75%
|
|
ABVC
ABVC BioPharma, Inc.
ABVC's pipeline includes oncology therapeutics derived from plant compounds and cancer-focused programs.
|
$32.08M |
$1.33
+8.13%
|
|
CELU
Celularity Inc.
Celularity's core products are allogeneic placental-derived cell therapies produced via the IMPACT platform.
|
$32.03M |
$1.15
-4.17%
|
|
BEAT
HeartBeam, Inc.
Direct diagnostic equipment derived from HeartBeam's synthesized 12-lead ECG device.
|
$31.69M |
$0.91
+12.48%
|
|
DYAI
Dyadic International, Inc.
Company directly produces recombinant proteins and enzymes (e.g., RHSA, transferrin, DNase1, RNase inhibitors, FGF, lactalbumin, lactoferrin) for life sciences, diagnostics, and food/industrial uses.
|
$31.66M |
$0.87
-1.35%
|
|
NEPH
Nephros, Inc.
FDA-cleared medical devices (infection-control filters) used in hospitals and dialysis centers.
|
$31.35M |
$2.96
+0.34%
|
|
IGC
IGC Pharma, Inc.
Direct Alzheimer’s disease therapeutics pipeline with IGC-AD1 and disease-modifying candidates, the core product focus.
|
$31.19M |
$0.33
+2.55%
|
|
GTHP
Guided Therapeutics, Inc.
LuViva is a point-of-care diagnostic device used for cervical cancer screening, which aligns with Diagnostic Equipment.
|
$30.93M |
$0.37
|
|
VNRX
VolitionRx Limited
VolitionRx's Nu.Q platform enables liquid biopsy cancer diagnostics by detecting nucleosome/epigenetic biomarkers in blood.
|
$30.74M |
$0.36
+26.22%
|
|
KTCC
Key Tronic Corporation
Vietnam medical device manufacturing capability highlighted, aligning with Medical Devices & Biometrics.
|
$30.30M |
$2.73
-0.55%
|
|
RADX
Radiopharm Theranostics Limited
Core product category: Radiopharmaceuticals used for diagnostic imaging and therapy in oncology.
|
$30.24M |
$4.62
-0.32%
|
|
PDSB
PDS Biotechnology Corporation
Company is a oncology-focused biotech developing novel immunotherapies for HPV-related cancers (HPV16+ HNSCC).
|
$29.85M |
$0.66
+2.39%
|
|
ELUT
Elutia Inc.
Elutia's EluPro is a cardiology device used with cardiac implanted electronic devices (CIEDs), directly tying to Cardiology Devices.
|
$29.59M |
$0.70
-0.37%
|
|
TVGN
Tevogen Bio Holdings Inc.
ExacTcell off-the-shelf T cell therapies and the TVGN 489 program position Tevogen as a cell therapy biotech focused on oncology and infectious disease.
|
$29.33M |
$7.42
+16.59%
|
|
BTAI
BioXcel Therapeutics, Inc.
BXCL501 is a small-molecule drug delivered as an oral dissolving film; fits 'Oral Small Molecule Therapeutics'.
|
$29.26M |
$2.04
-1.69%
|
|
IKNA
Ikena Oncology, Inc.
ImageneBio's lead asset IMG-007 is a monoclonal antibody targeting OX40 for immunological/inflammatory diseases, aligning with Immunology Therapeutics.
|
$29.04M |
$7.22
|
|
STCB
Starco Brands, Inc.
Vertical integration via acquisition of The Starco Group provides contract manufacturing capabilities.
|
$29.02M |
$0.04
|
|
PLUR
Pluri Inc.
PluriCDMO provides cell-therapy manufacturing services, generating revenue and serving as a core business line.
|
$28.78M |
$3.17
+1.28%
|
|
JSPR
Jasper Therapeutics, Inc.
Core product briquilimab is a monoclonal antibody therapeutic, fitting Monoclonal Antibody Therapeutics.
|
$28.54M |
$1.01
+5.08%
|
|
EKSO
Ekso Bionics Holdings, Inc.
Product portfolio includes Ekso Indego Personal and EksoNR, both medical devices used for rehabilitation and mobility assistance.
|
$28.36M |
$10.77
+3.56%
|
|
EVAX
Evaxion Biotech A/S
Evaxion develops vaccines, including EVX-01 for cancer and multiple infectious-disease vaccine programs.
|
$28.11M |
$4.50
+8.70%
|
|
LTRN
Lantern Pharma Inc.
Lantern is a biotech company with a focused oncology pipeline and programs.
|
$27.75M |
$2.52
-1.95%
|
Showing page 30 of 38 (3734 total stocks)
Loading company comparison...
Loading industry trends...
Loading research report...
